FDA approves Kiwi acne medicine for US sale
West Auckland-based Douglas Pharmaceuticals has gained approval to sell its acne medication in the United States, and says it is the first New Zealand-developed human medicine to be approved for use there.
Director Jeff Douglas said Food and Drug Administration approval for the drug – called isotretinoin – was a huge breakthrough for the firm, which had spent 10 years trying to enter the US$400 million ($494 million) acne medication market. "It’s our biggest export product and is the market leader in Spain, Austria, Germany and Mexico," Douglas said. New Zealand Herald – Read more…